AU Stock MarketDetailed Quotes
PAB Patrys Ltd
- 0.005
- +0.001+25.00%
20min DelayMarket Closed Nov 27 10:06 AET
10.29MMarket Cap-2500P/E (Static)
0.005High0.005Low251.96KVolume0.005Open0.004Pre Close1.26KTurnover0.01052wk High0.02%Turnover Ratio2.06BShares0.00352wk Low-0.002EPS TTM6.95MFloat Cap0.619Historical HighLossP/E (Static)1.39BShs Float0.003Historical Low-0.002EPS LYR0.00%Amplitude--Dividend TTM2.50P/B1Lot Size--Div YieldTTM
About Patrys Ltd Company
Patrys Ltd focuses on the development of natural human antibody-based therapies for the treatment of cancer. The company's product includes Deoxymab 3E10, PAT-SC1, PAT-DX1 PAT-DX1-NP, PAT-DX3, and PAT-LM1. Its main technology is Deoxymab 3E10, a DNA damage repair (DDR) antibody that penetrates live cell nuclei and inhibits key mechanisms of DNA repair in target cancer cells.
Company Profile
SymbolPAB
Company NamePatrys Ltd
Founded2006
MarketASX
Fiscal Year Ends06-30
AddressLevel 4, 100 Albert Road South Melbourne
CityMelbourne
CountryAustralia
Zip Code3205
Phone+61 396703273
Websitehttps://www.patrys.com
Share RegistryCOMPUTERSHARE INVESTOR SERVICES PTY LIMITED
Yarra Falls, 452 Johnston Street, ABBOTSFORD, VIC, AUSTRALIA, 3067
03 9415 4000
Company Executives
- Name
- Position
- Salary
- James Campbell
- Chief Executive Officer,Managing Director
- --
- Charmaine Gittleson
- Non-Executive Chairman,Non-Executive Director
- --
- Michael Stork
- Non-Executive Director,Non-Executive Deputy Chairman
- --
- Pamela M Klein
- Non-Executive Director
- --
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
% Chg
No Data